Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Bellerophon Therapeutics Inc (BLPH)

Bellerophon Therapeutics Inc (BLPH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0120 -0.0041 (-25.47%) 12/18/24 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0120 unch (unch) -
Quote Overview for Wed, Dec 18th, 2024
Day Low
0.0120
Day High
0.0126
Open 0.0120
Previous Close 0.0161 0.0161
Volume 7,000 7,000
Avg Vol N/A N/A
Stochastic %K N/A N/A
Weighted Alpha N/A N/A
5-Day Change N/A (-1.64%) N/A (-1.64%)
52-Week Range 0.0116 - 0.0190 0.0116 - 0.0190
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 122
  • Shares Outstanding, K 12,233
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,830 K
  • EBIT $ -14 M
  • EBITDA $ -14 M
  • 60-Month Beta 0.74
  • Price/Sales 0.19
  • Price/Cash Flow N/A
  • Price/Book 0.07
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.33
  • Most Recent Earnings N/A on 08/14/23
  • Next Earnings Date 12/17/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Most Recent Stories

More News
Bellerophon Therapeutics: Q3 Earnings Snapshot

Bellerophon Therapeutics: Q3 Earnings Snapshot

BLPH : 0.0120 (-25.47%)
Bellerophon Therapeutics: Q1 Earnings Snapshot

Bellerophon Therapeutics: Q1 Earnings Snapshot

BLPH : 0.0120 (-25.47%)
Bellerophon Therapeutics: Q3 Earnings Snapshot

Bellerophon Therapeutics: Q3 Earnings Snapshot

BLPH : 0.0120 (-25.47%)
Bellerophon Announces Poster Presentation at Upcoming American Thoracic Society 2022 International Conference

WARREN, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage...

BLPH : 0.0120 (-25.47%)
Bellerophon Provides Clinical Program Update and Reports First Quarter 2022 Financial Results

WARREN, N.J., May 11, 2022 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage...

BLPH : 0.0120 (-25.47%)
Bellerophon Provides Clinical Program Update and Reports Full-Year 2021 Financial Results

WARREN, N.J., March 31, 2022 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage...

BLPH : 0.0120 (-25.47%)
Bellerophon to Present at the H.C. Wainwright BioConnect 2022 Conference

WARREN, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage...

BLPH : 0.0120 (-25.47%)
Bellerophon Reports Positive Top-Line Data from Phase 2 Acute Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Sarcoidosis

Phase 2 results provide clinically meaningful reduction in pulmonary vascular resistance; Company intends to design multi-dose Phase 2b trial Treatment...

BLPH : 0.0120 (-25.47%)
Bellerophon Therapeutics: Q3 Earnings Snapshot

WARREN, N.J. (AP) _ Bellerophon Therapeutics Inc. (BLPH) on Monday reported a loss of $4.6 million in its third quarter.

BLPH : 0.0120 (-25.47%)
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2021 Financial Results

WARREN, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage...

BLPH : 0.0120 (-25.47%)

Business Summary

Bellerophon Therapeutics LLC is a biotherapeutics company. It is focused on developing products for the treatment of cardiopulmonary and cardiac diseases. The company's product pipeline consists of INOpulse and BCM which are in different clinical stage. Bellerophon Therapeutics LLC is based in Hampton,...

See More

Key Turning Points

3rd Resistance Point 0.0130
2nd Resistance Point 0.0128
1st Resistance Point 0.0124
Last Price 0.0120
1st Support Level 0.0118
2nd Support Level 0.0116
3rd Support Level 0.0112

See More

52-Week High 0.0190
Fibonacci 61.8% 0.0162
Fibonacci 50% 0.0153
Fibonacci 38.2% 0.0144
Last Price 0.0120
52-Week Low 0.0116

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro